Category:James D. McIninch of Burlington MA (US)

James D. McIninch of Burlington MA (US)

Executive Summary

James D. McIninch of Burlington MA (US) is an inventor who has filed 10 patents. Their primary areas of innovation include MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (5 patents), of the backbone (5 patents), {against enzymes (viral enzymes (5 patents), and they have worked with companies such as Alnylam Pharmaceuticals, Inc. (10 patents). Their most frequent collaborators include (7 collaborations), (5 collaborations), (3 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
• C12N2310/315 (of the backbone): 5 patents
• C12N15/1137 ({against enzymes (viral enzymes): 5 patents
• A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids}): 4 patents
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 4 patents
• C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 4 patents
• C12N2310/3515 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N2310/321 (2'-O-R Modification): 3 patents
• C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N2310/3125 (of the backbone): 3 patents
• C12N2310/322 (2'-R Modification): 2 patents
• C12N2310/53 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N15/1138 ({against receptors or cell surface proteins}): 1 patents
• C12N2320/30 (Special therapeutic applications): 1 patents
• C12Y304/21109 (ENZYMES): 1 patents
• A61K9/0019 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents
• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
• A61P7/02 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• C12N2310/313 (of the backbone): 1 patents
• C12N15/66 (General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease): 1 patents
• C12N2310/31 (of the backbone): 1 patents
• A61P43/00 (Drugs for specific purposes, not provided for in groups): 1 patents
• A61P3/00 (Drugs for disorders of the metabolism (of the blood or the extracellular fluid): 1 patents
• C12N2310/316 (of the backbone): 1 patents
• A61P25/00 (Drugs for disorders of the nervous system): 1 patents
• C12N9/0089 (Enzymes; Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth): 1 patents
• C12N2310/111 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2320/31 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12Y115/01001 (ENZYMES): 1 patents
• A61K47/02 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• C12N2310/314 (of the backbone): 1 patents

Companies

List of Companies

• Alnylam Pharmaceuticals, Inc.: 10 patents

Collaborators

• Mark K. Schlegel of Boston MA (US) (7 collaborations)
• Adam Castoreno of Framingham MA (US) (5 collaborations)
• Charalambos Kaittanis of Cambridge MA (US) (3 collaborations)
• Tuyen M. Nguyen of Milton MA (US) (2 collaborations)
• Mark Keating of Weston MA (US) (2 collaborations)
• Elane Fishilevich of Rochester MA (US) (2 collaborations)
• Kristina Yucius of Burlington MA (US) (2 collaborations)
• Haiyan Peng of Medford MA (US) (1 collaborations)
• Bret Lee Bostwick of Cambridge MA (US) (1 collaborations)
• Aimee M. Deaton of Somerville MA (US) (1 collaborations)
• John Michael Gansner of Newton MA (US) (1 collaborations)
• Benjamin P. Garfinkel of Brookline MA (US) (1 collaborations)
• Sarah Solomon of Cambridge MA (US) (1 collaborations)
• David Erbe of Arlington MA (US) (1 collaborations)
• Lan Thi Hoang Dang of Arlington MA (US) (1 collaborations)
• Aarti Sharma-Kanning of Tarrytown NY (US) (1 collaborations)
• David Frendewey of Tarrytown NY (US) (1 collaborations)
• Brittany Savage of Tarrytown NY (US) (1 collaborations)
• Lucas D. BonDurant of Brookline MA (US) (1 collaborations)
• Jason Gilbert of Hingham MA (US) (1 collaborations)
• Stuart Milstein of Arlington MA (US) (1 collaborations)
• Leila Noetzli of Boston MA (US) (1 collaborations)
• Frederic Tremblay of Boston MA (US) (1 collaborations)